Novotech Featured Reports

  1. Clostridium Difficile Infection (CDI): Asia Pacific Clinical Trial Landscape 9/29/2022

    Clostridium difficile infection is one of the leading causes of morbidity and mortality worldwide. Find out more about this disease in Asia, where a mean overall prevalence of nearly 15.0% was found among hospital patients.

  2. Non-Alcoholic Steatohepatitis (NASH): Asia Pacific Clinical Trial Landscape 9/29/2022

    Even though NAFLD (non-alcoholic fatty liver disease) is a significant public health burden in the United States and Europe, learn why Asia has a NAFLD burden that is increasing faster than the developed countries of the West.

  3. Ulcerative Colitis: The Asia Pacific Clinical Trial Landscape 9/29/2022

    Find out how the incidence and prevalence of Ulcerative Colitis in Asia has rapidly increased over the past four decades with an incidence rate of around 6 cases per 100,000 population.